January 2023. Looking to transition from paper lab notebooks or scattered spreadsheets to a centralized data system? The Uncountable platform provides a structured data management solution, allowing your R&D data to be understood organization-wide.
Benefits of Uncountable as an ELN
• Standardization
• Collaboration
• Visualizations & Analytics
• Audit & Compliance
• Workflows
Allow your scientists to collaborate and learn from each other, with searching, commenting and request features.
• Quickly find relevant experiments, based on inputs, outputs, calculations and other variables
• Leave comments that notify other team members
• Use results of 1 experiment as inputs to another, allowing teams to work together across projects
• Utilize real time editing of workbooks, allowing users to see who is working on documents
• Assign work to certain users, based on your lab's needs.
We have a motivated, diverse team in San Francisco, New York, and Munich that is developing a set of transformative solutions to tackle this problem.
Source: Uncountable Inc.
Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld\'s sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.
B2Bioworld offers you background information
A view from quantum optics and interfaces between Physics, Information, and Biology.
Coping with Customers’ Response to Lock-in Tactics of Mass Spec-Manufacturers
Christof von Kalle, at the time Head of Germany’s National Center for Tumor Diseases on new approaches to achieve tangible clinical results – or to manoeuvring into dead ends
Scientist Irene Coin about labs which impacted her research at Universities of Padua (IT), Leipzig (DE), Biodesign Institute (AZ,US), or the Salk Institute(CA,US)
Ulrich Betz, Vice President Department Head Innovation & Entrepreneurship Incubator; Merck Biopharma
Insights and Experience viewed from Evonik Industries